RECURSION PHARMACEUTICALS, INC. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
RECURSION PHARMACEUTICALS, INC. (RXRX) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $353.10 million as of 2021-12-31, per its 10-K filed 2022-03-23.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2022-03-23
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $353.10M.
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $193.80M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2021-12-31 | $353.10M 10-K · filed 2022-03-23 |
| 2020-12-31 | $193.80M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |